Three highlights:
1. Dr. Radcliffe is an ophthalmic surgeon at the Microincisional Glaucoma Surgery Center at New York Eye and Ear Infirmary at Mount Sinai in New York City.
2. With the board members’ expertise and leadership, ELT Sight hopes to begin conducting clinical testing of its ExTra ELT laser device in 2020.
3. The company is also eyeing U.S. regulatory approval for the device, which is designed to lower intraocular pressure in glaucoma patients after microinvasive surgery. ExTra ELT has already gained CE mark approval in Europe.
More articles on surgery centers:
50 years of ASCs: 5 things to know
7 critical steps for financial success in your ASC
Delaware medical group opens surgery, wellness center
